2-Tellurium-bridged β-cyclodextrin, a thioredoxin reductase inhibitor, sensitizes human breast cancer cells to TRAIL-induced apoptosis through DR5 induction and NF-κB suppression (Q82473319)
Jump to navigation
Jump to search
scientific article published on 16 November 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | 2-Tellurium-bridged β-cyclodextrin, a thioredoxin reductase inhibitor, sensitizes human breast cancer cells to TRAIL-induced apoptosis through DR5 induction and NF-κB suppression |
scientific article published on 16 November 2010 |
Statements
1 reference
2-Tellurium-bridged β-cyclodextrin, a thioredoxin reductase inhibitor, sensitizes human breast cancer cells to TRAIL-induced apoptosis through DR5 induction and NF-κB suppression (English)
Tingting Lin
Zhiying Ding
Nan Li
Jiayun Xu
Guimin Luo
Junqiu Liu
16 November 2010
1 reference